遺伝子編集市場：技術、用途、エンドユーザー、製品・サービス、提供方法別-2025-2030年世界予測

遺伝子編集市場は、2023年に78億9,000万米ドルと評価され、2024年には91億8,000万米ドルに達すると予測され、CAGR 17.81％で成長し、2030年には248億7,000万米ドルになると予測されています。

遺伝子編集は、生物のDNA配列に特定の意図的な変更を加える方法と定義され、その精密さ、効率性、幅広い応用範囲により、さまざまな分野で計り知れない可能性を秘めています。遺伝子編集の必要性は、遺伝的疾患の修正、農業生産性の向上、ヘルスケアにおける新規治療法の開発など、重要な課題に対処する能力に根ざしています。生物医学研究、農業、創薬から再生医療に至るまで、その応用分野は多岐にわたり、現代科学における万能ツールとなっています。最終用途は、製薬、バイオテクノロジー、農業、学術研究機関など多岐にわたる。市場成長の原動力となっているのは、CRISPR-Cas9のような遺伝子編集技術の進歩、官民からの資金提供の増加、遺伝子組み換え作物や遺伝子治療に対する需要の高まりです。しかし、倫理的な懸念、規制上の課題、高コストが急速な市場普及を抑制する大きな制約となっています。さらに、CRISPR技術の複雑さとオフターゲット効果は、普及を妨げる技術的課題となっています。重要な機会は、従来の用途にとどまらず、合成生物学やバイオ燃料のような分野にも応用を拡大することにあります。このような潜在的機会を活用するために、企業はコストを削減し、遺伝子編集技術の精度を向上させる技術革新に注力すべきであり、その結果、その応用可能性と社会的受容性が高まる。遺伝子編集の結果を予測するための人工知能と機械学習の統合や、調査を迅速化するための潜在的なCRISPRライブラリーは、技術革新の有望な分野を提供します。しかし、地域によって規制状況が異なるため、よりスムーズな市場参入と普及のためには戦略的なナビゲーションが必要です。市場競争は激しく、急速な技術進歩と絶え間ないイノベーションの必要性が特徴です。そのため、遺伝子編集技術の潜在能力を最大限に引き出し、倫理的な実施を導くためには、公的機関、民間企業、規制機関の広範な協力が不可欠です。

市場力学：急速に進化する遺伝子編集市場の主要市場インサイトを公開

遺伝子編集市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 革新的な治療ソリューションを必要とする遺伝性疾患や障害の有病率の増加
  • 臨床応用におけるCRISPRやその他の先端技術の採用拡大
  • ゲノミクスおよび遺伝子治療研究に対する政府および民間セクターの資金提供の拡大
• 市場抑制要因
  • 遺伝子編集技術に関する高コストと倫理的懸念
• 市場機会
  • 遺伝子編集と人工知能（AI）など他の先端技術との統合
  • 遺伝子編集の進歩を促進する遺伝子研究およびバイオテクノロジーへの投資の増加
• 市場の課題
  • 遺伝子編集に関する技術的・倫理的課題

ポーターの5つの力：遺伝子編集市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、遺伝子編集市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：遺伝子編集市場における外部からの影響の把握

外部マクロ環境要因は、遺伝子編集市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析遺伝子編集市場における競合情勢の把握

遺伝子編集市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的な意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス遺伝子編集市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、遺伝子編集市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨遺伝子編集市場における成功への道筋を描く

遺伝子編集市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 革新的な治療法を必要とする遺伝性疾患や障害の増加
    • 臨床応用におけるCRISPRやその他の先進技術の採用増加
    • ゲノミクスと遺伝子治療調査に対する政府と民間部門の資金提供の拡大
  • 抑制要因
    • 遺伝子編集技術に関する高コストと倫理的懸念
  • 機会
    • 遺伝子編集と人工知能（AI）などの他の先進技術との統合
    • 遺伝子調査とバイオテクノロジーへの投資増加が遺伝子編集の進歩を促進
  • 課題
    • 遺伝子編集に関連する技術的および倫理的な課題
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 遺伝子編集市場：技術別

• クリスパー
• メガヌクレアーゼ
• TALENs
• ジンクフィンガーヌクレアーゼ（ZFN）

第7章 遺伝子編集市場：用途別

• 農業用途
  • 作物の強化
  • 家畜遺伝子工学
• 臨床応用
  • 細胞株エンジニアリング
  • 遺伝子治療
• 調査アプリケーション
  • 遺伝子機能研究
  • 幹細胞調査

第8章 遺伝子編集市場：エンドユーザー別

• 学術調査機関
• 契約調査機関
• 製薬・バイオテクノロジー企業

第9章 遺伝子編集市場：製品・サービス別

• 消耗品
  • キットと試薬
  • 図書館
• 機器
• サービス

第10章 遺伝子編集市場配送方法別

• 生物学的方法
  • 非ウイルス性の方法
  • ウイルスベクター
• 物理的方法
  • エレクトロポレーション
  • マイクロインジェクション

第11章 南北アメリカの遺伝子編集市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域の遺伝子編集市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカの遺伝子編集市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• 1. Bayer CropScience
• 2. Beam Therapeutics
• 3. Bluebird Bio
• 4. Caribou Biosciences
• 5. Cellectis
• 6. Cibus
• 7. CRISPR Therapeutics
• 8. Editas Medicine
• 9. Genscript Biotech
• 10. Horizon Discovery
• 11. Inscripta
• 12. Intellia Therapeutics
• 13. Lonza Group
• 14. Pioneer Hi-Bred International Inc.
• 15. Precision Biosciences
• 16. Regeneron Pharmaceuticals
• 17. Sangamo Therapeutics
• 18. Syngenta AG
• 19. Synthego
• 20. Thermo Fisher Scientific

LIST OF FIGURES

• FIGURE 1. GENE EDITING MARKET RESEARCH PROCESS
• FIGURE 2. GENE EDITING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL GENE EDITING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL GENE EDITING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL GENE EDITING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL GENE EDITING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL GENE EDITING MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL GENE EDITING MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. AMERICAS GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES GENE EDITING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 19. UNITED STATES GENE EDITING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. GENE EDITING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 25. GENE EDITING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. GENE EDITING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL GENE EDITING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL GENE EDITING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL GENE EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. GENE EDITING MARKET DYNAMICS
• TABLE 7. GLOBAL GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL GENE EDITING MARKET SIZE, BY CRISPR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL GENE EDITING MARKET SIZE, BY MEGANUCLEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL GENE EDITING MARKET SIZE, BY TALENS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL GENE EDITING MARKET SIZE, BY ZINC FINGER NUCLEASES (ZFNS), BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL GENE EDITING MARKET SIZE, BY CROP ENHANCEMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL GENE EDITING MARKET SIZE, BY LIVESTOCK GENETIC ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL GENE EDITING MARKET SIZE, BY CELL LINE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL GENE EDITING MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL GENE EDITING MARKET SIZE, BY GENE FUNCTION STUDIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL GENE EDITING MARKET SIZE, BY STEM CELL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL GENE EDITING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL GENE EDITING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL GENE EDITING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL GENE EDITING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL GENE EDITING MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL GENE EDITING MARKET SIZE, BY LIBRARIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL GENE EDITING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL GENE EDITING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL GENE EDITING MARKET SIZE, BY NON-VIRAL METHODS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 39. GLOBAL GENE EDITING MARKET SIZE, BY VIRAL VECTORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 40. GLOBAL GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 41. GLOBAL GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 42. GLOBAL GENE EDITING MARKET SIZE, BY ELECTROPORATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 43. GLOBAL GENE EDITING MARKET SIZE, BY MICROINJECTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 44. GLOBAL GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 45. AMERICAS GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 46. AMERICAS GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. AMERICAS GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 48. AMERICAS GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 49. AMERICAS GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 50. AMERICAS GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 51. AMERICAS GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 52. AMERICAS GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 53. AMERICAS GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
• TABLE 54. AMERICAS GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 55. AMERICAS GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 56. AMERICAS GENE EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 57. ARGENTINA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 58. ARGENTINA GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. ARGENTINA GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 60. ARGENTINA GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 61. ARGENTINA GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 62. ARGENTINA GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 63. ARGENTINA GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 64. ARGENTINA GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 65. ARGENTINA GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
• TABLE 66. ARGENTINA GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 67. ARGENTINA GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 68. BRAZIL GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 69. BRAZIL GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. BRAZIL GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 71. BRAZIL GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 72. BRAZIL GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 73. BRAZIL GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 74. BRAZIL GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 75. BRAZIL GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 76. BRAZIL GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
• TABLE 77. BRAZIL GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 78. BRAZIL GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 79. CANADA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 80. CANADA GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. CANADA GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 82. CANADA GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 83. CANADA GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 84. CANADA GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 85. CANADA GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 86. CANADA GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 87. CANADA GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
• TABLE 88. CANADA GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 89. CANADA GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 90. MEXICO GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 91. MEXICO GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. MEXICO GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 93. MEXICO GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 94. MEXICO GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 95. MEXICO GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 96. MEXICO GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 97. MEXICO GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 98. MEXICO GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
• TABLE 99. MEXICO GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 100. MEXICO GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 101. UNITED STATES GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 102. UNITED STATES GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. UNITED STATES GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 104. UNITED STATES GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 105. UNITED STATES GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 106. UNITED STATES GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 107. UNITED STATES GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 108. UNITED STATES GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 109. UNITED STATES GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
• TABLE 110. UNITED STATES GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 111. UNITED STATES GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 112. UNITED STATES GENE EDITING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 113. ASIA-PACIFIC GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 114. ASIA-PACIFIC GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 115. ASIA-PACIFIC GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 116. ASIA-PACIFIC GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 117. ASIA-PACIFIC GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 118. ASIA-PACIFIC GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 119. ASIA-PACIFIC GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 120. ASIA-PACIFIC GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 121. ASIA-PACIFIC GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
• TABLE 122. ASIA-PACIFIC GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 123. ASIA-PACIFIC GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 124. ASIA-PACIFIC GENE EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 125. AUSTRALIA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 126. AUSTRALIA GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. AUSTRALIA GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 128. AUSTRALIA GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 129. AUSTRALIA GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 130. AUSTRALIA GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 131. AUSTRALIA GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 132. AUSTRALIA GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 133. AUSTRALIA GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
• TABLE 134. AUSTRALIA GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 135. AUSTRALIA GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 136. CHINA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 137. CHINA GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. CHINA GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 139. CHINA GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 140. CHINA GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 141. CHINA GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 142. CHINA GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 143. CHINA GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 144. CHINA GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
• TABLE 145. CHINA GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 146. CHINA GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 147. INDIA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 148. INDIA GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 149. INDIA GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 150. INDIA GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 151. INDIA GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 152. INDIA GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 153. INDIA GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 154. INDIA GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 155. INDIA GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
• TABLE 156. INDIA GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 157. INDIA GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 158. INDONESIA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 159. INDONESIA GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 160. INDONESIA GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 161. INDONESIA GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 162. INDONESIA GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 163. INDONESIA GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 164. INDONESIA GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 165. INDONESIA GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 166. INDONESIA GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
• TABLE 167. INDONESIA GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 168. INDONESIA GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 169. JAPAN GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 170. JAPAN GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 171. JAPAN GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 172. JAPAN GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 173. JAPAN GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 174. JAPAN GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 175. JAPAN GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 176. JAPAN GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 177. JAPAN GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
• TABLE 178. JAPAN GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 179. JAPAN GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 180. MALAYSIA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 181. MALAYSIA GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 182. MALAYSIA GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 183. MALAYSIA GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 184. MALAYSIA GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 185. MALAYSIA GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 186. MALAYSIA GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 187. MALAYSIA GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 188. MALAYSIA GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
• TABLE 189. MALAYSIA GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 190. MALAYSIA GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 191. PHILIPPINES GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 192. PHILIPPINES GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 193. PHILIPPINES GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 194. PHILIPPINES GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 195. PHILIPPINES GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 196. PHILIPPINES GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 197. PHILIPPINES GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 198. PHILIPPINES GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 199. PHILIPPINES GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
• TABLE 200. PHILIPPINES GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 201. PHILIPPINES GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 202. SINGAPORE GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 203. SINGAPORE GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 204. SINGAPORE GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 205. SINGAPORE GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 206. SINGAPORE GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 207. SINGAPORE GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 208. SINGAPORE GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 209. SINGAPORE GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 210. SINGAPORE GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
• TABLE 211. SINGAPORE GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 212. SINGAPORE GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 213. SOUTH KOREA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 214. SOUTH KOREA GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 215. SOUTH KOREA GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 216. SOUTH KOREA GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 217. SOUTH KOREA GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 218. SOUTH KOREA GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 219. SOUTH KOREA GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 220. SOUTH KOREA GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 221. SOUTH KOREA GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
• TABLE 222. SOUTH KOREA GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 223. SOUTH KOREA GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 224. TAIWAN GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 225. TAIWAN GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 226. TAIWAN GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 227. TAIWAN GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 228. TAIWAN GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 229. TAIWAN GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 230. TAIWAN GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 231. TAIWAN GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 232. TAIWAN GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
• TABLE 233. TAIWAN GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 234. TAIWAN GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 235. THAILAND GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 236. THAILAND GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 237. THAILAND GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 238. THAILAND GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 239. THAILAND GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 240. THAILAND GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 241. THAILAND GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 242. THAILAND GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 243. THAILAND GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
• TABLE 244. THAILAND GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 245. THAILAND GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 246. VIETNAM GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 247. VIETNAM GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 248. VIETNAM GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 249. VIETNAM GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 250. VIETNAM GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 251. VIETNAM GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 252. VIETNAM GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 253. VIETNAM GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 254. VIETNAM GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
• TABLE 255. VIETNAM GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 256. VIETNAM GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 257. EUROPE, MIDDLE EAST & AFRICA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 258. EUROPE, MIDDLE EAST & AFRICA GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 259. EUROPE, MIDDLE EAST & AFRICA GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 260. EUROPE, MIDDLE EAST & AFRICA GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 261. EUROPE, MIDDLE EAST & AFRICA GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 262. EUROPE, MIDDLE EAST & AFRICA GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 263. EUROPE, MIDDLE EAST & AFRICA GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 264. EUROPE, MIDDLE EAST & AFRICA GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 265. EUROPE, MIDDLE EAST & AFRICA GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
• TABLE 266. EUROPE, MIDDLE EAST & AFRICA GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 267. EUROPE, MIDDLE EAST & AFRICA GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 268. EUROPE, MIDDLE EAST & AFRICA GENE EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 269. DENMARK GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 270. DENMARK GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 271. DENMARK GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 272. DENMARK GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 273. DENMARK GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 274. DENMARK GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 275. DENMARK GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 276. DENMARK GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 277. DENMARK GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
• TABLE 278. DENMARK GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 279. DENMARK GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 280. EGYPT GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 281. EGYPT GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 282. EGYPT GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 283. EGYPT GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 284. EGYPT GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 285. EGYPT GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 286. EGYPT GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 287. EGYPT GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 288. EGYPT GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
• TABLE 289. EGYPT GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 290. EGYPT GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 291. FINLAND GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 292. FINLAND GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 293. FINLAND GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 294. FINLAND GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 295. FINLAND GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 296. FINLAND GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 297. FINLAND GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 298. FINLAND GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 299. FINLAND GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
• TABLE 300. FINLAND GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 301. FINLAND GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 302. FRANCE GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 303. FRANCE GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 304. FRANCE GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 305. FRANCE GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 306. FRANCE GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 307. FRANCE GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 308. FRANCE GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 309. FRANCE GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 310. FRANCE GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
• TABLE 311. FRANCE GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 312. FRANCE GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 313. GERMANY GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 314. GERMANY GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 315. GERMANY GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 316. GERMANY GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 317. GERMANY GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 318. GERMANY GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 319. GERMANY GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 320. GERMANY GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 321. GERMANY GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
• TABLE 322. GERMANY GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 323. GERMANY GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 324. ISRAEL GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 325. ISRAEL GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 326. ISRAEL GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 327. ISRAEL GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 328. ISRAEL GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 329. ISRAEL GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 330. ISRAEL GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 331. ISRAEL GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 332. ISRAEL GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
• TABLE 333. ISRAEL GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 334. ISRAEL GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 335. ITALY GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 336. ITALY GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 337. ITALY GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 338. ITALY GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 339. ITALY GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 340. ITALY GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 341. ITALY GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 342. ITALY GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 343. ITALY GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
• TABLE 344. ITALY GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 345. ITALY GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 346. NETHERLANDS GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 347. NETHERLANDS GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 348. NETHERLANDS GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 349. NETHERLANDS GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 350. NETHERLANDS GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 351. NETHERLANDS GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 352. NETHERLANDS GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 353. NETHERLANDS GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 354. NETHERLANDS GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
• TABLE 355. NETHERLANDS GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 356. NETHERLANDS GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
• TABLE 357. NIGERIA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 358. NIGERIA GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 359. NIGERIA GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 360. NIGERIA GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2

The Gene Editing Market was valued at USD 7.89 billion in 2023, expected to reach USD 9.18 billion in 2024, and is projected to grow at a CAGR of 17.81%, to USD 24.87 billion by 2030.

Gene editing, defined as a method of making specific and intentional changes to the DNA sequence of living organisms, holds immense potential across various sectors due to its precision, efficiency, and broad application scope. The necessity of gene editing is rooted in its ability to address critical challenges, such as correcting genetic disorders, improving agricultural productivity, and developing novel therapies in healthcare. Applications span sectors from biomedical research, agriculture, and drug discovery to regenerative medicine, making it a versatile tool in modern science. End-use scope is vast, including pharmaceuticals, biotechnology, agriculture, and academic research institutions. Market growth is driven by advances in gene-editing technologies like CRISPR-Cas9, increased funding from public and private sectors, and an escalating demand for genetically modified crops and gene therapies. However, ethical concerns, regulatory challenges, and high costs are significant limitations curbing rapid market adoption. Moreover, the complexity of CRISPR technology and off-target effects present technical challenges that hinder widespread use. Key opportunities lie in expanding applications beyond traditional uses to encompass areas like synthetic biology and biofuels. To capitalize on these potential opportunities, businesses should focus on innovations that reduce costs and improve the precision of gene-editing techniques, thus enhancing their applicability and public acceptance. The integration of artificial intelligence and machine learning to predict gene-edited outcomes and potential CRISPR libraries to expedite research offer promising areas of innovation. However, stringent regulatory landscapes across different regions necessitate strategic navigation to enable smoother market entry and adoption. The gene editing market is intensely competitive, characterized by rapid technological advancements and a need for constant innovation. Thus, widespread collaboration between public institutions, private players, and regulatory bodies is essential to harness the full potential and guide ethical implementation of gene-editing technologies.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Gene Editing Market

The Gene Editing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increased prevalence of genetic diseases and disorders requiring innovative treatment solutions
  • Growing adoption of CRISPR and other advanced technologies in clinical applications
  • Expanding governmental and private sector funding for genomics and gene therapy research
• Market Restraints
  • High costs and ethical concerns regarding gene-editing technologies
• Market Opportunities
  • Integration of gene editing with other advanced technologies such as artificial intelligence (AI)
  • Rising investment in genetic research and biotechnology to drive gene editing advancements
• Market Challenges
  • Technological and ethical challenges associated with gene editing

Porter's Five Forces: A Strategic Tool for Navigating the Gene Editing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Gene Editing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Gene Editing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Gene Editing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Gene Editing Market

A detailed market share analysis in the Gene Editing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Gene Editing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Gene Editing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Gene Editing Market

A strategic analysis of the Gene Editing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Gene Editing Market, highlighting leading vendors and their innovative profiles. These include Bayer CropScience, Beam Therapeutics, Bluebird Bio, Caribou Biosciences, Cellectis, Cibus, CRISPR Therapeutics, Editas Medicine, Genscript Biotech, Horizon Discovery, Inscripta, Intellia Therapeutics, Lonza Group, Pioneer Hi-Bred International Inc., Precision Biosciences, Regeneron Pharmaceuticals, Sangamo Therapeutics, Syngenta AG, Synthego, and Thermo Fisher Scientific.

Market Segmentation & Coverage

This research report categorizes the Gene Editing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Technology, market is studied across CRISPR, Meganucleases, TALENs, and Zinc Finger Nucleases (ZFNs).
• Based on Application, market is studied across Agricultural Applications, Clinical Applications, and Research Applications. The Agricultural Applications is further studied across Crop Enhancement and Livestock Genetic Engineering. The Clinical Applications is further studied across Cell Line Engineering and Gene Therapy. The Research Applications is further studied across Gene Function Studies and Stem Cell Research.
• Based on End User, market is studied across Academic & Research Institutes, Contract Research Organizations, and Pharmaceutical & Biotechnology Companies.
• Based on Product & Service, market is studied across Consumables, Instruments, and Services. The Consumables is further studied across Kits & Reagents and Libraries.
• Based on Delivery Method, market is studied across Biological Methods and Physical Methods. The Biological Methods is further studied across Non-Viral Methods and Viral Vectors. The Physical Methods is further studied across Electroporation and Microinjection.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increased prevalence of genetic diseases and disorders requiring innovative treatment solutions
    • 5.1.1.2. Growing adoption of CRISPR and other advanced technologies in clinical applications
    • 5.1.1.3. Expanding governmental and private sector funding for genomics and gene therapy research
  • 5.1.2. Restraints
    • 5.1.2.1. High costs and ethical concerns regarding gene-editing technologies
  • 5.1.3. Opportunities
    • 5.1.3.1. Integration of gene editing with other advanced technologies such as artificial intelligence (AI)

• 5.1.3.2. Rising investment in genetic research and biotechnology to drive gene editing advancements

• 5.1.4. Challenges
  • 5.1.4.1. Technological and ethical challenges associated with gene editing
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Gene Editing Market, by Technology

• 6.1. Introduction
• 6.2. CRISPR
• 6.3. Meganucleases
• 6.4. TALENs
• 6.5. Zinc Finger Nucleases (ZFNs)

7. Gene Editing Market, by Application

• 7.1. Introduction
• 7.2. Agricultural Applications
  • 7.2.1. Crop Enhancement
  • 7.2.2. Livestock Genetic Engineering
• 7.3. Clinical Applications
  • 7.3.1. Cell Line Engineering
  • 7.3.2. Gene Therapy
• 7.4. Research Applications
  • 7.4.1. Gene Function Studies
  • 7.4.2. Stem Cell Research

8. Gene Editing Market, by End User

• 8.1. Introduction
• 8.2. Academic & Research Institutes
• 8.3. Contract Research Organizations
• 8.4. Pharmaceutical & Biotechnology Companies

9. Gene Editing Market, by Product & Service

• 9.1. Introduction
• 9.2. Consumables
  • 9.2.1. Kits & Reagents
  • 9.2.2. Libraries
• 9.3. Instruments
• 9.4. Services

10. Gene Editing Market, by Delivery Method

• 10.1. Introduction
• 10.2. Biological Methods
  • 10.2.1. Non-Viral Methods
  • 10.2.2. Viral Vectors
• 10.3. Physical Methods
  • 10.3.1. Electroporation
  • 10.3.2. Microinjection

11. Americas Gene Editing Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Gene Editing Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Gene Editing Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Bayer CropScience
• 2. Beam Therapeutics
• 3. Bluebird Bio
• 4. Caribou Biosciences
• 5. Cellectis
• 6. Cibus
• 7. CRISPR Therapeutics
• 8. Editas Medicine
• 9. Genscript Biotech
• 10. Horizon Discovery
• 11. Inscripta
• 12. Intellia Therapeutics
• 13. Lonza Group
• 14. Pioneer Hi-Bred International Inc.
• 15. Precision Biosciences
• 16. Regeneron Pharmaceuticals
• 17. Sangamo Therapeutics
• 18. Syngenta AG
• 19. Synthego
• 20. Thermo Fisher Scientific